STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 60 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $405,000 | -31.4% | 198,534 | 0.0% | 0.02% | -28.6% |
| Q2 2021 | $590,000 | +7.7% | 198,534 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $548,000 | +13.7% | 198,534 | 0.0% | 0.02% | +5.0% |
| Q4 2020 | $482,000 | +15.6% | 198,534 | 0.0% | 0.02% | +5.3% |
| Q3 2020 | $417,000 | -44.4% | 198,534 | 0.0% | 0.02% | -50.0% |
| Q2 2020 | $750,000 | +100.0% | 198,534 | 0.0% | 0.04% | +72.7% |
| Q1 2020 | $375,000 | -9.6% | 198,534 | 0.0% | 0.02% | +15.8% |
| Q4 2019 | $415,000 | – | 198,534 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,604,065 | $29,586,000 | 35.89% |
| Opaleye Management Inc. | 1,390,000 | $6,227,000 | 2.32% |
| Prosight Management, LP | 937,900 | $4,202,000 | 2.17% |
| Broadfin Capital, LLC | 2,821,722 | $12,641,000 | 1.66% |
| 22NW, LP | 404,410 | $1,812,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 2,878,000 | $12,893,000 | 0.98% |
| NEA Management Company, LLC | 4,141,308 | $18,553,000 | 0.74% |
| Harvest Capital Strategies LLC | 543,652 | $2,436,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 931,600 | $4,174,000 | 0.47% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 988,750 | $4,430,000 | 0.35% |